Core Viewpoint - Ningbo Suobao Protein Technology Co., Ltd. announced a cash dividend distribution plan for the first three quarters of 2025, with a cash dividend of 0.07 RMB per share, totaling approximately 13.4 million RMB [2][4]. Summary by Sections Dividend Distribution - The cash dividend distribution is set at 0.07 RMB per share, with a total distribution amounting to 13,402,137.35 RMB based on a total share capital of 191,459,105 shares [2][4]. Shareholder Meeting - The profit distribution plan was approved at the company's first extraordinary general meeting on January 16, 2026 [2]. Distribution Objects - The distribution applies to all shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the equity registration [3]. Implementation Method - For shareholders with unrestricted circulating shares, dividends will be distributed through the clearing system of China Securities Depository and Clearing Corporation Limited. Shareholders who have completed designated transactions can collect their cash dividends on the distribution date [5]. Taxation Details - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.07 RMB per share. For those holding shares for one year or less, the tax will be calculated upon the transfer of shares [9]. - For shareholders holding restricted shares, a 10% tax will be withheld, resulting in a net distribution of 0.063 RMB per share [10]. - Qualified Foreign Institutional Investors (QFIIs) will also receive a net distribution of 0.063 RMB per share after a 10% tax withholding [11]. - Other corporate shareholders will not have taxes withheld by the company, and the gross dividend of 0.07 RMB per share will be distributed [12].

Group 1 - The company's operating revenue for the first half of 2025 reached 774 million yuan, representing a year-on-year growth of 0.24% [1] - The net profit for the same period was 97.43 million yuan, showing a significant year-on-year increase of 37.62% [1]

Group 1 - The company achieved a revenue of 645 million yuan in 2024, representing an 18.65% year-on-year increase, while the net profit attributable to shareholders was 124 million yuan, down 19.38% [1] - In Q4 2024, the company reported a single-quarter revenue of 182 million yuan, up 38.50%, and a net profit of 40.34 million yuan, an increase of 58.63% [1] - For Q1 2025, the revenue was 186 million yuan, reflecting a 27.73% increase, with a net profit of 40.58 million yuan, up 32.31% [1] Group 2 - After excluding the impact of COVID-19, the company's revenue for 2024 was 620 million yuan, a 24% increase, with domestic revenue at 216 million yuan (+16.8%) and international revenue at 429 million yuan (+19.6%) [2] - The company maintained a gross margin above 90%, with a sales expense ratio of 32.1% (+1.3 percentage points) due to increased overseas market expansion and a research and development expense ratio of 25.63% (+2.7 percentage points) [2] - In Q1 2025, the company expects to see the benefits of scale, with a total expense ratio of 62.7% (-1.0 percentage points) and a sales expense ratio of 28.7% (-3.7 percentage points) [2] Group 3 - The company is enhancing its product diversity, with over 5,000 products available in 2024, and has successfully developed nearly 50 GMP-grade products [3] - The overseas business grew by 25% in 2024, accounting for 66% of total revenue, with the establishment of multiple overseas subsidiaries and four global warehousing centers [3] - The company plans to further develop overseas production bases to improve global supply chain resilience, anticipating significant growth potential in international markets [3] Group 4 - Revenue forecasts for 2025-2026 have been adjusted to 801 million yuan and 970 million yuan, respectively, while net profit estimates have been revised down to 161 million yuan and 216 million yuan [4] - The company is projected to achieve revenues and net profits of 1.159 billion yuan and 264 million yuan by 2027, with current stock prices reflecting P/E ratios of 36, 27, and 22 for 2025-2027 [4]